Skip to main content

Polio Vaccine

Polio Vaccine

The inactivated polio vaccine (or IPV) is now the only vaccine given in the United States to prevent polio. IPV is given as a series of four shots at 2 months, 4 months, 6 to 18 months, and again at 4 to 6 years of age.

The face of polio

President Franklin Delano Roosevelt, paralyzed by polio, was confined to a wheelchair for most of his adult life. President Roosevelt caught polio when he was in his late 30s. Only about 1 in 10 people who were paralyzed by polio recovered — most were confined to wheelchairs or iron lungs (a large machine to help breathing) for the rest of their lives.

Watch this video, “The Iron Lung and Polio,” by Mark Rockoff, MD for OPENPediatrics to learn more about the iron lung.

The disease

What is polio?

Polio is caused by a virus and is highly contagious. It affects people differently — some don't feel sick at all, others complain of anything from a sore throat to fever, stomach pain or vomiting, stiff neck or headache. The virus does its damage by first replicating, or reproducing, itself in the intestines, then traveling through the bloodstream where it can infect the brain and spinal cord. Paralysis caused by polio occurs when the virus replicates in and attacks the nervous system.

Polio vaccine has been available since 1955. The inactivated polio vaccine (IPV) was available first, given as a shot, in 1955. A more convenient form, called oral polio vaccine (OPV), was given as liquid drops via the mouth. It was developed in 1961. OPV was recommended for use in the United States for almost 40 years, from 1963 until 2000. The results have been miraculous: Polio was eliminated from the United States in 1979 and from the Western Hemisphere in 1991.

Since 2000, only IPV is recommended to prevent polio in the United States.

Read personal stories about polio

The vaccine

How were the "inactivated" (IPV) and "oral" (OPV) poliovirus vaccines made?

OPV was made by weakening the three strains of poliovirus that caused disease by growing them in monkey kidney cells. Poliovirus that was grown in these cells was so "weakened" that, after it was swallowed, it induced an immune response but didn't cause disease. OPV induced antibodies in the intestines and, therefore, because polio enters the body through the intestines, provided a "first line" of defense against polio. Unfortunately, on occasion, OPV reverted back to the natural form, causing paralysis.

IPV, unlike OPV, cannot reproduce itself (or replicate) and, therefore, cannot possibly revert back to natural polio. To make IPV, poliovirus is purified and killed with a chemical (formaldehyde). IPV elicits antibodies in the bloodstream, not the intestines. It prevents the virus from traveling through the blood to the brain or spinal cord, thereby preventing paralysis. In a sense, because the vaccine induces antibodies in the bloodstream, and not the intestines, IPV induces a "second line" of defense against infection.

Why do we use the polio shot (IPV) and not the oral polio vaccine (OPV)?

In about 1 of every 2.4 million recipients, the live, weakened virus contained in the oral polio vaccine causes paralysis. The shot does not have this same side effect because, unlike the oral version, the shot contains killed virus that cannot replicate and, therefore, cannot cause paralysis.

Between 1961 and 1996, children in the United States received four doses of the oral vaccine. This changed beginning in 1997 and continued throughout 1999 when children typically received two doses of the shot followed by two doses of the oral vaccine. Since that time, infants have received four doses of the shot.

Many other countries continue to use the oral polio vaccine because it is more economical and easier to administer, allowing more people to get the vaccine. It also provides better community immunity.

Other questions you might have

2022 NY Polio Case: Why and What Does It Mean?

Polio was eliminated from the United States in 1979; however, on a few occasions, cases have been identified in this country. During the fall of 2022, an unvaccinated man in Rockland County, New York, was paralyzed as a result of a polio infection. The NY man was infected with a type of poliovirus that came from the oral polio vaccine, called vaccine-derived paralytic polio. The case was concerning because we know that only about 1 of every 2,000 people infected with this vaccine-derived strain will be paralyzed, meaning that many others are likely also being exposed to this virus. High vaccination rates in most U.S. communities mean that often we remain unaware of the presence of the virus, but recent drops in routine immunizations following the pandemic have left some communities more vulnerable.

In this video, Dr. Paul Offit discusses the history of polio and the polio vaccines — inactivated polio vaccine (IPV) and oral polio vaccine (OPV). He explains why in rare instances OPV reverts to wildtype virus and the mechanism by which unvaccinated individuals can also get paralytic polio.

  • Paul Offit, MD: Hi, my name is Paul Offit. I'm talking to you today from the Vaccine Education Center at the Children's Hospital of Philadelphia. It's Friday, December 9th, 2022. Well, this summer something unusual happened in Rockland County, New York, and that is that a 27-year-old unvaccinated man was paralyzed by poliovirus.  

    Now, we eliminated poliovirus from the United States by 1979. So, what's happening? And I think to understand what happened to this man, we need to go back to the beginning, which is the mid-1950s at a time when polio would paralyze 25[,000] to 30,000 children a year, would cause 1,500 children to die every year because we didn't have a vaccine. But in the middle of the 1950s, around 1955, Jonas Salk made a polio vaccine. He made it by taking the virus, growing it up in cell culture, purifying it, and then completely inactivating it with a chemical, a so-called whole killed viral vaccine. And we used that vaccine in the United States from 1955 up until 1962.  

    in 1962, that vaccine was replaced by Albert Sabin's vaccine, which was a live-weakened form of the virus. We have other live-weakened viral vaccines, like the measles vaccine, or the mumps vaccine, or the German measles (or rubella vaccine), or one of the rotavirus vaccines, or the chickenpox vaccine. Those are all made the same way by taking a virus, in this case poliovirus, and there's three strains of poliovirus, strains 1, 2, and 3, and what Dr. Sabin did was he weakened those viruses, the natural viruses, the wildtype viruses, by growing them up in cell culture, in monkey cells. And that vaccine then was then used in the United States from the early 1960s up until around the year 2000, and it eliminated polio from the United States by 1979; it eliminated polio from the Western hemisphere by 1994. But unfortunately, there was a problem with that vaccine, and it wasn't trivial, and that was that in some people, and it was extremely rare, roughly 1 out of every 2.4 million people who got that vaccine would develop paralysis caused by the vaccine virus. Because the vaccine virus, which would reproduce itself in the intestine over and over again, could occasionally revert to essentially so-called neurovirulent strain or a wildtype strain. I mean, it really, it caused a clinical syndrome indistinguishable from polio. So, in other words, this was called vaccine-associated paralytic polio, and it was rare, but it was real.  

    So, although we eliminated polio from the United States by 1979, throughout the 1980s, throughout the 1990s, every year, eight to 10 children would be paralyzed by that vaccine. For that reason, in the year 2000, we then eliminated the use of the oral polio vaccine. Albert Sabin's oral polio, live-attenuated viral vaccine was eliminated for use in this country in 2000. So, for 20 years now, more than 20 years, we have only used the inactivated vaccine, and that's why we then eliminated even vaccine-associated paralytic polio. But there are many countries that still use the oral polio vaccine, and for that reason, there are those viruses, those revertant viruses, those vaccine-associated paralytic polio strains, still circulate. And that's what happened to this man. What happened to this man was that he was, because he was unvaccinated, that virus, that type 2 revertant virus that was originally derived from Albert Sabin's polio, Albert Sabin's live-attenuated polio vaccine, that caused him to be paralyzed. 

    Now, know this, know that only about 1 of every 2,000 people who are infected with that vaccine-derived strain will become paralyzed. So, his case of paralysis represents the tip of a much, much bigger iceberg. And you know that's true because what has happened at that point was, we looked at wastewater in Rockland County, looked at wastewater in surrounding counties, like Sullivan County, Ocean County, and found that there was this type 2 revertant virus, this vaccine-associated virus was in the wastewater, so that says that at least thousands, and possibly tens of thousands, and possibly hundreds of thousands of people could have been infected with that virus. Now, the inactivated polio vaccine, which we use in this country and have only used since the year 2000, is very good at preventing poliovirus from entering the bloodstream and traveling to the brain or spinal cord and causing harm. So, anybody who’s vaccinated with the inactivated polio vaccine will be prevented from getting polio if they are infected with this type 2 revertant strain from the vaccine. But the inactivated vaccine doesn't induce intestinal immunity. So, you could be infected with this type 2 revertant paralytic strain and shed it in your stool, and then pass it on to others. You'll never be paralyzed, and those who are vaccinated will never be paralyzed, but they can still spread the virus.  

    So, I think what we need to do, what it's important to do now, is to look in the wastewater not only in New York or in Rockland County, but in Philadelphia; in Portland, Oregon; in Las Vegas, Nevada; in Los Angeles, California; in Indianapolis, Indiana, to answer the question, how prevalent is this particular strain? This neurovirulent type 2 strain that was derived from the vaccine, which you know is circulating throughout the world and may well be circulating in this country. And if we find that that's true, it just makes it all the more important to make sure that we've gotten the inactivated vaccine, which will then prevent us from being paralyzed by this virus but won't prevent us from transmitting this virus. This is an easily solved problem, just make sure everybody who's gotten the inactivated vaccine gets it. If you're an older person like me and you got the oral polio vaccine … you got the inactivated vaccine in the '50s and then the oral vaccine in the 1960s, or if you got the oral polio vaccine from the 1960s up till the year 2000, you are protected against this virus, but you're not protected if you're not vaccinated. So, we need to make sure that everybody's vaccinated and we're going to learn, I think, over the next few months or year just how common this particular type two revertant strain is in this country.  

    Thank you. 

Transcript Transcript

Relative risks and benefits

Do the benefits of the inactivated polio vaccine (IPV) outweigh its risks?

Natural polio has been eliminated from the United States since 1979. However, polio has not been eliminated from the rest of the world. Efforts to eradicate polio have proven challenging. Polio has never been successfully eliminated from Pakistan, Afghanistan and Nigeria. Until the spread of natural poliovirus is stopped in these countries, all countries remain at risk for the return of polio. Groups dedicated to eradicating polio continue to work toward elimination. To follow their progress, check www.polioeradication.org.

Since travel makes the world a much smaller place, a recurrence of polio is merely a plane ride away. In countries with high immunization rates, this is less likely, but the potential for spread of polio exists when people are not immunized. Because IPV has no serious side effects, the benefits of the vaccine clearly outweigh its risks.

Disease risks

  • Sore throat, fever, stomach pain or vomiting, stiff neck or headache
  • Permanent paralysis
  • Disease can be fatal

Vaccine risks

  • Pain, redness and swelling at the injection site

Reference

Orenstein W, Offit PA, Edwards KM and Plotkin SA. Poliovirus vaccine-inactivated and poliovirus vaccine-live in Vaccines, 8th Edition, 2024, 890-968.

Reviewed by Paul A. Offit, MD, on January 02, 2024

Jump back to top